Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Labanca

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignanciesEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Expert Review of Hematology|May 15, 2024
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemiaAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|April 13, 2025
Rilzabrutinib for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Expert Opinion on Pharmacotherapy|December 25, 2025
Reshaping multiple myeloma treatment: recent breakthroughsEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|May 25, 2026
Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric AssessmentAntonella Bruzzese, Enrica Antonia Martino, Santino Caserta, et al.
Expert Review of Hematology|June 25, 2025
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent <i>versus</i> combination drugsEnrica Antonia Martino, Ernesto Vigna, Caterina Labanca, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignanciesEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Expert Review of Hematology|May 15, 2024
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemiaAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|April 13, 2025
Rilzabrutinib for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Pageof 6